| 000 | 01417 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250513122445.0 | ||
| 264 | 0 | _c19970807 | |
| 008 | 199708s 0 0 eng d | ||
| 022 | _a0022-3565 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNegus, S S | |
| 245 | 0 | 0 |
_aEffects of kappa opioids on cocaine self-administration by rhesus monkeys. _h[electronic resource] |
| 260 |
_bThe Journal of pharmacology and experimental therapeutics _cJul 1997 |
||
| 300 |
_a44-55 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _a3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCircadian Rhythm |
| 650 | 0 | 4 |
_aCocaine _xadministration & dosage |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEthylketocyclazocine _xpharmacology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aMacaca mulatta |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNaloxone _xpharmacology |
| 650 | 0 | 4 |
_aNaltrexone _xanalogs & derivatives |
| 650 | 0 | 4 |
_aPyrrolidines _xpharmacology |
| 650 | 0 | 4 |
_aReceptors, Opioid, kappa _xagonists |
| 650 | 0 | 4 | _aSelf Administration |
| 650 | 0 | 4 |
_aSubstance-Related Disorders _xdrug therapy |
| 700 | 1 | _aMello, N K | |
| 700 | 1 | _aPortoghese, P S | |
| 700 | 1 | _aLin, C E | |
| 773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 282 _gno. 1 _gp. 44-55 |
|
| 999 |
_c9203799 _d9203799 |
||